Dr-Lalchandani-Labs (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE notifies listing and trading permission for 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis, effective … | |||||||||||||||
BSE notifies listing and trading permission for 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis, effective March 6, 2026.
| |||||||||||||||
BSE lists 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis, effective March 6, 2026. | |||||||||||||||
BSE lists 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis, effective March 6, 2026.
| |||||||||||||||
BSE notifies trading members that 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis are listed and permitted … | |||||||||||||||
BSE notifies trading members that 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis are listed and permitted to trade from March 6, 2026.
| |||||||||||||||
BSE lists 43,04,000 new equity shares of DR LALCHANDANI LABS LIMITED issued on rights basis, effective March 6, 2026. Shares are ranked … | |||||||||||||||
BSE lists 43,04,000 new equity shares of DR LALCHANDANI LABS LIMITED issued on rights basis, effective March 6, 2026. Shares are ranked pari-passu with existing equity shares.
| |||||||||||||||
Trading in Rights Entitlements (REs) for DR Lalchandani Labs Limited commences on February 04, 2026, with renunciation period ending … | |||||||||||||||
Trading in Rights Entitlements (REs) for DR Lalchandani Labs Limited commences on February 04, 2026, with renunciation period ending February 17, 2026.
| |||||||||||||||